Unusual dermatological toxicity of hydroxyurea in two dogs with spontaneously occurring tumours

Journal of Small Animal Practice

Volumn 48, Issue 9, 2007, Pages 514-517

  Marconato, L ^a   Bonfanti, U ^b,d   Fileccia, I ^c  

^a Clinica Veterinaria L'Arca   (Italy)

^b Clinica Veterinaria Gran Sasso   (Italy)

^c Clinica Veterinaria Preneste   (Italy)

^d NERVIANO MEDICAL SCIENCES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROXYUREA;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DOG; DOG DISEASE; FEMALE; FOOT DISEASE; HOOF AND CLAW; MALE; PATHOLOGY; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; DOG DISEASES; DOGS; FEMALE; FOOT DISEASES; HOOF AND CLAW; HYDROXYUREA; MALE; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 34548421960     PISSN: 00224510     EISSN: 17485827     Source Type: Journal    
DOI: 10.1111/j.1748-5827.2006.00301.x     Document Type: Article

References (33)

1. Bass, M. C. Schultze, A. E 1998) Essential thrombocythemia in a dog: case report and literature review. Journal of the American Animal Hospital Association 34, 197 203
2. Bravo Blanco, A. M., Moral, J. L., Tembras, S., Gomez, R., Ulibarrena, C. Obdulia Vazquez, M 2003) Hydroxyurea-induced skin ulcerations in patients with chronic myeloproliferative disorders. Journal of Hematotherapy & Stem Cell Research 12, 461 463
3. Chun, R., Garrett, L. MacEwen, E. G 2001) Cancer chemotherapy. In : Small Animal Clinical Oncology. 3rd edn. Eds S. J. Withrow and E. G. MacEwen. W. B. Saunders, Philadelphia, PA, USA. pp 92 118
4. Conroy, J. D 1983) An overview of immune-mediated mucocutaneous diseases in the dog and cat. II. Other diseases based on immunologic mechanisms. The American Journal of Dermatopathology 5, 595 599
5. Cusimano, M. D 1998) Hydroxyurea for treatment of meningioma. Journal of Neurosurgery 88, 938 939
6. Favier, R. P., van Leeuwen, M. Teske, E 2004) Essential thrombocythaemia in two dogs. Tijdschrift voor Diergeneeskunde 129, 360 364
7. Fine, D. M. Tvedten, H. W 1999) Chronic granulocytic leukemia in a dog. Journal of the American Veterinary Medical Association 214, 1809 1812
8. Fingeroth, J. M., Prata, R. G. Patnaik, A. K 1987) Spinal meningiomas in dogs: 13 cases (1972-1987). Journal of the American Veterinary Medical Association 191, 720 726
9. Forrester, S. D. Rogers, K. S 2000) Hyperviscosity syndrome. In : Schalm's Veterinary Hematology. Eds B. F. Feldman, J. G. Zinkl and N. C. Jain. Lippincott Williams & Wilkins, Philadelphia, PA, USA. pp 929 931
10. Friedrich, S., Raff, K., Landthaler, M. Karrer, S 2004) Cutaneous ulcerations on hands and heels secondary to long-term hydroxyurea treatment. European Journal of Dermatology 14, 343 346
11. Gerritsen, R. J., Teske, E., Kraus, J. S. Rutteman, G. R 1998) Multi-agent chemotherapy for mast cell tumours in the dog. The Veterinary Quarterly 20, 28 31
12. Gray, H. E., Weigand, C. M., Cottrill, N. B., Willis, A. M. Morgan, R. V 2003) Polycythemia vera in a dog presenting with uveitis. Journal of the American Animal Hospital Association 39, 355 360
13. Gross, T. L., Ihrke, P. J., Walder, E. J. Affolter, V. K 2005) Interface diseases of the dermal-epidermal junction. In : Skin Diseases of the Dog and Cat. 2nd edn. Eds T. L. Gross, P. J. Ihrke, E. J. Walder and V. K. Affolter. Blackwell Science Ltd, Oxford, UK. pp 49 74
14. Gutheil, J. C. Finucane, D. M 2001) Antimetabolites. In : The Chemotherapy Source Book. Ed M. C. Perry. Lippincott Williams & Wilkins, Philadelphia, PA, USA. pp 223 224
15. Kato, N., Kimura, K., Yasukawa, K. Yoshida, K 1999) Hydroxyurea-related leg ulcers in a patient with chronic myelogenous leukemia: a case report and review of the literature. The Journal of Dermatology 26, 56 62
16. Lanore, D. Delprat, C 2002) Principaux agents. In : Chimiothérapie Anticancéreuse. Eds D. Lanore and C. Delprat. Masson-AFVAC, Paris, France. pp 76 77
17. Las Heras, G. Junca Piera, J 1998) Nail changes after chemotherapy. Haematologica 83, 748
18. Leifer, C. E., Matus, R. E., Patnaik, A. K. MacEwen, E. G 1983) Chronic myelogenous leukemia in the dog. Journal of the American Veterinary Medical Association 183, 686 689
19. Levy, M. S., Kapatkin, A. S., Patnaik, A. K., Mauldin, G. N. Mauldin, G. E 1997) Spinal tumors in 37 dogs: clinical outcome and long-term survival (1987-1994). Journal of the American Animal Hospital Association 33, 307 312
20. MacEwen, E. G., Drazner, F. H., McClelland, A. J. Wilkins, R. J 1975) Treatment of basophilic leukemia in a dog. Journal of the American Veterinary Medical Association 166, 376 380
21. Mason, W. P., Gentili, F., MacDonald, D. R., Hariharan, S., Cruz, C. R. Abrey, L. E 2002) Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma Journal of Neurosurgery 97, 341 346
22. Mears, E. A., Raskin, R. E. Legendre, A. M 1997) Basophilic leukemia in a dog. Journal of Veterinary Internal Medicine 11, 92 94
23. Newton, H. B., Slivka, M. A. Stevens, C 2000) Hydroxyurea chemotherapy for unresectable or residual meningioma. Journal of Neuro-Oncology 49, 165 170
24. Perkins, M. Watson, A 2001) Successful treatment of hypereosinophilic syndrome in a dog. Australian Veterinary Journal 79, 686 689
25. Peterson, M. E. Randolph, J. F 1982) Diagnosis of canine primary polycythemia and management with hydroxyurea. Journal of the American Veterinary Medical Association 180, 415 418
26. Rosenthal, M. A., Ashley, D. L. Cher, L 2002) Treatment of high risk or recurrent meningiomas with hydroxyurea. Journal of Clinical Neuroscience 9, 156 158
27. Schrell, U. M., Rittig, M. G., Anders, M., Koch, U. H., Marschalek, R., Kiesewetter, F. Fahlbusch, R 1997a) Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. Journal of Neurosurgery 86, 840 844
28. Schrell, U. M., Rittig, M. G., Anders, M., Kiesewetter, F., Marschalek, R., Koch, U. H. Fahlbusch, R 1997b) Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. Journal of Neurosurgery 86, 845 852
29. Scott, D. W., Rousselle, S. Miller, W. H. Jr. (1995) Symmetrical lupoid onychodystrophy in dogs: a retrospective analysis of 18 cases (1989-1993). Journal of the American Animal Hospital Association 31, 194 201
30. Turek, M. M 2003) Cutaneous paraneoplastic syndromes in dogs and cats: a review of the literature. Veterinary Dermatology 14, 279 296
31. Vassallo, C., Passamonti, F., Merante, S., Ardigo, M., Nolli, G., Mangiacavalli, S. Borroni, G 2001) Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia. Clinical and Experimental Dermatology 26, 141 148
32. Veterinary Cooperative Oncology Group (2004) Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Veterinary and Comparative Oncology 2, 194 213
33. Werner, L. L., Brown, K. A. Halliwell, R. E 1983) Diagnosis of autoimmune skin disease in the dog: correlation between histopathologic, direct immunofluorescent and clinical findings. Veterinary Immunology and Immunopathology 5, 47 64